Leadership Team
Terry L. Murdock
President, Chief Executive Officer, Director
Terry Murdock is a seasoned biopharmaceutical operations executive with over 25 years of experience guiding early- and emerging-stage companies from discovery through pivotal trials, regulatory approvals, and commercialization. Recognized for scaling organizations in oncology, autoimmune, and rare diseases, Terry combines clinical operations expertise, quality and inspection excellence, digital transformation, and board-level strategy to deliver programs that accelerate milestones and strengthen investor confidence.
He brings the rare combination of financial stewardship, operational discipline, clinical development leadership, and commercialization expertise that enables early-stage biopharma to scale with confidence and speed from discovery to launch.
He brings the rare combination of financial stewardship, operational discipline, clinical development leadership, and commercialization expertise that enables early-stage biopharma to scale with confidence and speed from discovery to launch.
Constance Neely Wilson, M.D.
Chief Scientific Officer, Founder and Director
Dr. Constance Neely Wilson completed postdoctoral research in Pulmonary Medicine and fellowships in Respiratory Intensive Care and Cardiology at Massachusetts General Hospital. She is a board-certified anesthesiologist and critical care physician-scientist with extensive expertise in cardiopulmonary medicine. Dr. Wilson earned her M.D. from the University of Virginia and her B.S. in Chemistry from Madison College.
Prior to September 2000, she was known as Constance Fisher Neely.